@arancaytar @LauraMiers @ZJemptv Type 2 polio circulating. It's not in the vax anymore. https://t.co/ItvP36aqQr
@michaelzlin 4 reads: 1) start of the conditions that led to cVDPV2 proliferation https://t.co/P2BnpNeSFH 2) How it didn't work out as hoped https://t.co/IuEE2hdhVU 3) That the failure isn't very surprising https://t.co/O41k70yMgk 4) Overview of vax &
@PolarniLiska +Yay "OPV2 is a live, attenuated virus, capable of genetic reversion to a neurovirulent phenotype that imposes a health burden due to vaccine-associated paralytic polio (VAPP). " https://t.co/XIUJcxHQPn
@HelenaHauser @Suffolklord man made polio is not almost eradicated https://t.co/37yjBXDCre
RT @BMCMedicine: #ThursdayThrowback published last year in @BMCMedicine : The risk of type 2 oral polio vaccine use in post-cessation outbr…
RT @BMCMedicine: #ThursdayThrowback published last year in @BMCMedicine : The risk of type 2 oral polio vaccine use in post-cessation outbr…
#ThursdayThrowback published last year in @BMCMedicine : The risk of type 2 oral polio vaccine use in post-cessation outbreak response https://t.co/gPche2k1au And the link commentary here: Models and analyses to understand threats to polio eradication htt
#OpenAccess: The risk of type 2 OPV use in post-cessation outbreak response | @BioMedCentral https://t.co/IuCZl842DQ #Vaccines #EndPolio https://t.co/yWtp8kL52M
#MathematicalModelling shows that type2 oral #PolioVaccine use should be managed carefully in #outbreak response: https://t.co/A6KBIk5EPm https://t.co/J85uUhE6CY
The risk of type 2 oral #PolioVaccine use in post-cessation #outbreak response - a #MathematicalModelling study: https://t.co/A6KBIk5EPm https://t.co/DcPmvRVKiD